| Net sales | 98.5M |
| Cost of sales | 19.88M |
| Gross profit | 78.62M |
| Sales and marketing | 41.72M |
| General and administrative | 18.58M |
| Research and development | 6.86M |
| Amortization of intangible assets | |
| Gain on sale of vascular operations (Note 16) | |
| Charges related to U.S. Government inquiries (Note 17) | |
| Operating Expenses, Total | 69.35M |
| Operating income (loss) | 9.27M |
| Interest expense, net | |
| Gain on interest rate swap | |
| Other income (expense), net | -634K |
| Nonoperating Income (Expense), Total | -163K |
| Income (loss) before income taxes | |
| Income tax expense | 1.28M |
| Net income (loss) | 9.9M |
| Basic | 0.55 |
| Diluted | 0.54 |
| Basic | 18.09M |
| Diluted | 18.38M |